Jonathan Licht, MD

Chief, Division of Medicine-Hematology/Oncology
Johanna Dobe Professor of Hematology/Oncology
Associate Director for Clinical Sciences Research, Robert H. Lurie Comprehensive Cancer Center
Feinberg School of Medicine

Research Interests
Prior to joining the Cancer Center, Dr. Licht was the Chief of the Division of Hematology/Oncology at the Mount Sinai School of Medicine in New York. He is a graduate of Columbia University College of Physicians and Surgeons and was a resident at Beth Israel Hospital, Harvard Medical School. He did his fellowship training in Medical Oncology at the Dana Farber Cancer Institute.
Understanding aberrant transcriptional repression as a cause of hematological malignancy, including acute promyelocytic leukemia and large cell lymphoma is the broad goal of Dr. Licht's research program, and he is utilizing small molecules and peptide interference strategies to reverse this repression. He also studies kidney development and signal transduction as an outgrowth of studies of the WT1 tumor suppressor.

Dr. Licht was a recipient of a Leukemia Society Scholar Award and currently holds a Burroughs-Wellcome Clinical Scientist Award in Translational Research. He is a Councilor of the American Society of Clinical Investigation and a member of the Association of American Physicians. Dr. Licht is a charter member of the NIH Cancer Molecular Pathology Study section and has served on American Cancer Society and Leukemia and Lymphoma Society review panels.